T3	Effect 21 49	decrease in plasma potassium
T5	Treatment 61 80	phosphate treatment
T6	Subject 101 170	a 24-year-old hypertensive patient with hypophosphatemic osteomalacia
T7	Age 103 114	24-year-old
T8	Sub-Disorder 115 127	hypertensive
T10	Drug 61 70	phosphate
T11	Treat-Disorder 141 170	hypophosphatemic osteomalacia
